The Food and Drug Administration (FDA) has authorized a new batch of the one-dose Johnson & Johnson CCP (Chinese Communist Party) virus vaccine. In a statement on Tuesday, the agency said it authorized a batch of the J&J vaccine made at a facility in Baltimore run by Emergent BioSolutions, bringing the total number of FDA-authorized J&J batches made at the facility to three. The FDA did not specify how many doses were in the new batch authorized under the emergency use authorization (EUA). Federal authorities in April halted production of the J&J vaccine at the site after they discovered that ingredients from AstraZeneca’s COVID-19 vaccine, also being produced at the plant at the time, contaminated a batch of J&J’s vaccine. An FDA inspection also turned up a long list of sanitary problems and bad manufacturing practices at the Emergent plant. J&J was put in charge of manufacturing at the plant and AstraZeneca’s shot is …